Investor Presentaiton
Research Services (Syngene): A global CRO delivering innovative solutions
$
THE
small
Offering integrated research, development and manufacturing services for
both
and large molecules, antibody-drug conjugates and
oligonucleotides backed by best-in-class bioinformatic services
Combining world class research expertise, technology and infrastructure to
reduce costs and time to market
Talented scientific and techno-commercial teams, led by experienced
management, moving beyond cost arbitrage to innovation.
World class infrastructure audited successfully by US FDA, EMA, AAALAC and
major life sciences partners
360+ active marquee clients across multiple sectors
World-class R&D and manufacturing infrastructure spread over 1.9 million
square feet
5000+ strong pool of employees, 4,200+ scientists
Strong track record of top-line growth with best-in-class EBITDA margins
(30+%) and Net Profit margin (high teens to low 20's)
Listed in India on BSE and NSE in 2015
Touching a billion
lives through
affordable innovation
Biocon
12View entire presentation